Get ready for a landmark event as Thailand hosts ISTH 2024 Congress, led by the International Society on Thrombosis and Haemostasis (ISTH). This 32nd annual scientific meeting, dedicated to thrombosis, hemostasis, and vascular biology, will take place from June 22 to 26, 2024, at the Queen Sirikit National Convention Center. With thousands of global medical and scientific experts expected to attend, this will be the largest medical conference ever held at the venue, occupying over 70% of its space.
The ISTH Congress 2024 stands as the pinnacle international meeting in thrombosis and hemostasis, showcasing the latest breakthroughs and clinical advancements. A convergence of clinicians, researchers, educators, allied healthcare professionals, and industry leaders will exchange the latest innovations and spearhead progress in understanding, preventing, diagnosing, and treating thrombotic and bleeding disorders. Networking opportunities will abound, allowing attendees to foster collaboration and share knowledge. This international meeting marks a return for the ISTH to the Asian region, following the 2011 Congress in Kyoto, Japan, and marks Thailand's debut as host, showcasing its workforce potential, medical innovations, and leading healthcare systems in the Southeast Asian landscape.
Flora Peyvandi, M.D., Ph.D., ISTH President, said, "the Queen Sirikit National Convention Center in Bangkok was chosen for its central location for optimal convenience for our attendees. The venue caters to the diverse needs of our world-class ISTH 2024 Congress, facilitating poster presentations, educational sessions, state-of-the-art lectures, medical industry exhibits and professional networking opportunities."
"Thailand's designation as the host of ISTH 2024 Congress underscores the region's position as an innovative gathering hub for the medical and scientific industries," said Prof. Pantep Angchaisuksiri, M.D., ISTH President Elect, 2024-2026 term, Professor of Medicine, and Chief of the Hemostasis and Thrombosis Unit at Ramathibodi Hospital, Mahidol University. "This meeting presents a pivotal opportunity for the Asia-Pacific scientific and clinical community to continue to make a lasting impact on prevention, diagnosis, and treatment of thrombosis and bleeding disorders, ultimately shaping the future of global healthcare practices in thrombosis and hemostasis."
Surapol Utintu, Chief Executive Officer of N.C.C. Management and Development Co., Ltd., the operator of QSNCC, expressed gratitude, saying, "We are deeply honored that Thailand and the QSNCC have been chosen to host the ISTH 2024 Congress. We are fully prepared to deliver a world-class experience with our state-of-the-art event spaces, top-notch facilities, and diverse retail options. Our goal is to ensure that this prestigious event exceeds expectations, leaving a lasting impression on attendees. By facilitating interactions and knowledge exchange, we are confident that the Congress will play a pivotal role in advancing thrombosis treatment and promoting global healthcare."
For more information about the ISTH 2024 Congress, visit www.isth2024.org.